FDA awarded nearly $3 million worth of grants to five universities to study and recommend improvements in the use of continuous manufacturing of biologics, an emerging manufacturing technique the agency says will reduce manufacturing costs and drive down drug prices. The goal of the grants is to encourage the establishment of high-tech manufacturing platforms in the United States, FDA Commissioner Scott Gottlieb said Thursday (Sept. 20). But as FDA aggressively pushes the new approach as a cost-saving measure, the generic...